FI833993A - 5-(substituerad fenyl)hydantoiner - Google Patents

5-(substituerad fenyl)hydantoiner Download PDF

Info

Publication number
FI833993A
FI833993A FI833993A FI833993A FI833993A FI 833993 A FI833993 A FI 833993A FI 833993 A FI833993 A FI 833993A FI 833993 A FI833993 A FI 833993A FI 833993 A FI833993 A FI 833993A
Authority
FI
Finland
Prior art keywords
hydantoiner
substituerad
fenyl
substituerad fenyl
Prior art date
Application number
FI833993A
Other languages
English (en)
Other versions
FI80265B (fi
FI833993A0 (fi
FI80265C (fi
Inventor
James P Rizzi
Rodney C Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI833993A0 publication Critical patent/FI833993A0/fi
Publication of FI833993A publication Critical patent/FI833993A/fi
Publication of FI80265B publication Critical patent/FI80265B/fi
Application granted granted Critical
Publication of FI80265C publication Critical patent/FI80265C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI833993A 1982-11-01 1983-10-31 Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-(substituerad-fenyl)hydantoiner. FI80265C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43819982 1982-11-01
US06/438,199 US4452806A (en) 1982-11-01 1982-11-01 Treating diabetic complications with 5-(substituted phenyl)hydantoins

Publications (4)

Publication Number Publication Date
FI833993A0 FI833993A0 (fi) 1983-10-31
FI833993A true FI833993A (fi) 1984-05-02
FI80265B FI80265B (fi) 1990-01-31
FI80265C FI80265C (fi) 1990-05-10

Family

ID=23739660

Family Applications (1)

Application Number Title Priority Date Filing Date
FI833993A FI80265C (fi) 1982-11-01 1983-10-31 Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-(substituerad-fenyl)hydantoiner.

Country Status (13)

Country Link
US (1) US4452806A (fi)
JP (1) JPS5998063A (fi)
KR (1) KR860001507B1 (fi)
CA (1) CA1203241A (fi)
DK (1) DK158724C (fi)
ES (1) ES8507119A1 (fi)
FI (1) FI80265C (fi)
GR (1) GR79638B (fi)
HU (1) HU191887B (fi)
PL (1) PL139646B1 (fi)
PT (1) PT77578A (fi)
YU (1) YU43556B (fi)
ZA (1) ZA838092B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100797422B1 (ko) 2000-09-25 2008-01-23 이비덴 가부시키가이샤 반도체소자, 반도체소자의 제조방법, 다층프린트배선판 및다층프린트배선판의 제조방법
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189587A (en) * 1977-04-05 1980-02-19 Ciba-Geigy Corporation 1,3-Diaminomethyl-hydantoin additives for lubricating oils
FR2458546A1 (fr) * 1979-06-07 1981-01-02 Hoechst France Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant

Also Published As

Publication number Publication date
CA1203241A (en) 1986-04-15
HU191887B (en) 1987-04-28
FI80265B (fi) 1990-01-31
DK499983A (da) 1984-05-02
DK158724C (da) 1990-11-19
ES526841A0 (es) 1985-05-01
YU43556B (en) 1989-08-31
JPH0465832B2 (fi) 1992-10-21
FI833993A0 (fi) 1983-10-31
DK158724B (da) 1990-07-09
US4452806A (en) 1984-06-05
YU216783A (en) 1986-02-28
PL139646B1 (en) 1987-02-28
DK499983D0 (da) 1983-11-01
ES8507119A1 (es) 1985-05-01
PT77578A (en) 1983-11-01
JPS5998063A (ja) 1984-06-06
ZA838092B (en) 1985-06-26
GR79638B (fi) 1984-10-31
KR860001507B1 (ko) 1986-09-30
PL244350A1 (en) 1985-02-13
KR840006630A (ko) 1984-12-01
FI80265C (fi) 1990-05-10

Similar Documents

Publication Publication Date Title
BE895653A (fr) Katalytische verbrander
FR2527098B1 (fr) No
AT388055B (de) Zielfernrohr
DK255083A (da) Substituerede pyridyl-phenyl-ethere
FI840912A0 (fi) Braensleinsprutningsanordning foer foerbraenningsmaskiner
FI833994A0 (fi) Aldosreduktaser inhibiterande 5-(2-alkoxi-3-substituerad fenyl)hydantoiner
FI833993A0 (fi) 5-(substituerad fenyl)hydantoiner
BE894865A (fr) Biertransportwagen
BE895921A (fr) Sterilet
DE3374006D1 (de) Substituted 4-fluoropyridaz-6-ones
ATA468282A (de) Drehrohrofen
ATA441982A (de) Hypsometer
ATA127782A (de) Ruestungstraeger
FI823772L (fi) Snoerlaos
IT8221572A1 (it) Tetratirochinoline sostituite
BR6201181U (pt) Varal
BR6200501U (pt) Mango-gas
FI833682A0 (fi) Filterspappersarkbunt
FI821368L (fi) Pressostatreglerad engreppsblandningsventil
FI821326A0 (fi) Axelsystem
BR6201241U (pt) Poli-movel
BR8202738A (pt) Passalama
BR6201022U (pt) Fiteiro
BR6200964U (pt) Plafonnier
BR6200901U (pt) Canudo sanfonado

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PFIZER INC.